ARTICLE | Company News
Dyax other research news
October 7, 1996 7:00 AM UTC
Dyax received a $100,000 Phase I SBIR grant from the NIH for preclinical development of an agent to image inflammation in several diseases. The agent is based on a small protein that targets neutrophi...